Washington, D.C. — The U.S. Food and Drug Administration has approved two new drugs to aid equine reproductive health.
The first approval concerns SucroMate Equine, which regulates ovulation in mares through a single injection to increase the likelihood of conception for both naturally bred and artificially inseminated horses. Manufactured by CreoSalus subsidiary Thorn BioScience in Louisville, Ky., the drug will be available to veterinarians through distributors by February, the start of the 2011 breeding season.
Click here to see more...